An evaluation was performed by reviewing the complaint text, reviewing other customer complaints for similar issues, accuracy testing, a review of labeling, and a review of historical records.The customer observed a potentially falsely elevated total psa result while using architect total psa reagent 7k70-25 lot 61499fn00.A review of complaints determined that there are no other complaints for this lot and no trends for the product.There was no patient sample available to assist in the investigation.Accuracy testing of a serum based panel was performed using a retained kit of lot 61499fn00.All specifications were met indicating that lot 61499fn00 is performing acceptably.A review of the manufacturing records did not identify any issues associated with the customer observation during the manufacturing of this lot.A review of labeling shows that there is adequate information provided to address the customer's issue of falsely elevated total psa results.Based on all available information and this investigation, the architect total psa reagent 7k70-25, lot 61499fn00, performed as intended and no product deficiency was identified.
|